ALB

Albemarle Corporation

Fundamental data last updated:June 4, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Basic Materials

industry

Chemicals - Specialty

Exchange

NYSE

County of HQ

US

Next Earnings Date

07/29/2026

Business Summary

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

 


VALUATION

P/E

-89.55

Market Cap ($M USD)

$20.87B

Forward P/E

10.99

PEG

0.01

PRICE TO SALES

3.80

PRICE TO BOOK

2.12

EV / EBITDA

27.01

5-Year Average P/E

Free Cash Flow Yield

2.77%

DCF Value

$-149.26

Graham Number

N/A

Price to FCF

36.15

EV to FCF

37.52

Earnings Yield

-1.12%

FCF Yield

2.77%

DIVIDEND

Yield

0.92%

Annual Payout

$1.62

Payout Ratio

-153.44%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

-$1.98

Next Year EPS Growth Estimate

$16.10

Next Year Revenue Growth Estimate

$790.40B

Return on Equity (ROE)

-2.35%

FREE CASH FLOW

Operating Margin

5.55%

Debt-to-Equity

0.35

Piotroski F-Score

5

Altman Z-Score

3.52

Return on Invested Capital (ROIC)

2.25%

Current Ratio

2.07

Quick Ratio

1.21

Net Debt to EBITDA

0.99

Interest Coverage

1.59

Gross Profit margin

18.53%

FCF PER SHARE

$4.90

REVENUE PER SHARE

$46.62

Gainseekers Quantitative Analysis

Summary

Albemarle Corporation’s valuation presents a perplexing picture. Despite a deeply negative DCF Value, the stock has traded above this metric, suggesting market optimism or mispricing. The Forward P/E of 14.28 indicates a more reasonable future outlook, contrasting sharply with the current negative Earnings Yield. The Altman Z-score of 3.87 suggests financial stability, yet the negative ROE and EPS highlight underlying profitability issues. Investors must weigh these conflicting signals carefully.

AI Exposure / Tech Reliance

Operating within the Chemicals - Specialty industry, Albemarle is strategically positioned to leverage AI and tech advancements in manufacturing processes. The sector's focus on innovation and efficiency could enhance production capabilities. However, the company's adaptability will depend on management's commitment to integrating these technologies effectively.

The Bull Case

For the discerning GARP investor, Albemarle offers intriguing potential. The Forward PEG ratio of 0.017 suggests significant undervaluation relative to growth expectations. With a Piotroski F-Score of 5 and a solid ROIC of 2.25%, the company demonstrates moderate financial health and capital efficiency. Its operating margin of 5.55% and manageable debt levels further bolster the case for its pricing power and operational resilience.

The Bear Case

Yet, the bear case cannot be ignored. Albemarle's Price/Book ratio of 2.44 and Price/Sales of 4.37 signal a potentially overvalued stock, especially when juxtaposed with its negative EPS and low FCF Yield of 0.024%. The stock's proximity to its 52-week high suggests technical overextension, raising concerns about its current valuation sustainability. Investors should be wary of these structural risks.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Hold

Average Analyst Price Target

$209.75

Institutional Ownership %

1-Year Beta

1.37

Insider Buying % (6 Mo)

Distance to 52-Week High

24.89%

Distance to 52-Week Low

69.65%

EARNINGS SURPRISE %

147.90%

50-DAY SMA

$184.26

200-DAY SMA

$140.01

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.